Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Thursday, July 9, 2026
🇺🇸 FDA

capivasertib News

🇺🇸 FDA ← All news

FDA capivasertib coverage for business development, investment, and market access teams

High impact NewsJun 15, 2026

FDA Approves Capivasertib for PTEN-Deficient Prostate Cancer

FDA · prostate cancer · 6 min

Dr. Sarah Mitchell
Critical impact NewsMay 1, 2026

FDA Advisory Committee Recommends AstraZeneca's TRUQAP for PTEN-Deficient Prostate Cancer

FDA · Oncology - Prostate Cancer · 3 min

James Chen, PharmD

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.